-
CVS/pharmacy expands ExtraCare Advantage for Diabetes program
WOONSOCKET, R.I. — In honor of National Diabetes Month in November, CVS/pharmacy is looking to further meet the healthcare needs of those people living with diabetes by expanding its ExtraCare Advantage for Diabetes program with new support and savings.
-
Acura Pharmaceuticals introduces PSE product that will be less attractive to 'meth cooks'
PALATINE, Ill. — Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine. Couched as the "next generation pseudoephedrine product," Nexafed is a 30-mg PSE hydrochloride tablet that utilizes Acura's trademarked Impede technology.